Latest Breaking News On - Adlai nortye - Page 1 : vimarsana.com

Adlai Nortye (NASDAQ:ANL) Shares Up 1.5%

Adlai Nortye Ltd. (NASDAQ:ANL – Get Free Report) shares rose 1.5% on Tuesday . The company traded as high as $7.08 and last traded at $6.23. Approximately 16,598 shares changed hands during trading, an increase of 76% from the average daily volume of 9,431 shares. The stock had previously closed at $6.14. Adlai Nortye Stock […]

Adlai Nortye Ltd. to Present Encouraging Data of the

Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024

Adlai Nortye Announces First Patient Dosed in Randomized Phase Ii Clinical Trial of Palupiprant for the Treatment of Locally Advanced Rectal Cancer with Radiation Therapy

Adlai Nortye Ltd. announced that the first patient was dosed in the Phase II clinical trial known as ARTEMIS . This clinical study evaluates palupiprant , a small molecule prostaglandin E receptor 4 ...

Adlai Nortye Ltd. (NASDAQ:ANL) Short Interest Update

Adlai Nortye (NASDAQ:ANL) Shares Gap Down to $14.80

Shares of Adlai Nortye Ltd. (NASDAQ:ANL – Get Free Report) gapped down before the market opened on Tuesday . The stock had previously closed at $14.80, but opened at $13.83. Adlai Nortye shares last traded at $13.83, with a volume of 444 shares. Analysts Set New Price Targets Separately, Cantor Fitzgerald reaffirmed an “overweight” rating […]

Adlai Nortye (NASDAQ:ANL) Shares Gap Down to $14.80

Adlai Nortye (NASDAQ:ANL) Shares Down 5.7%

Cantor Fitzgerald Research Analysts Raise Earnings Estimates for Adlai Nortye Ltd. (NASDAQ:ANL)

12 Health Care Stocks Moving In Friday's Intraday Session - AEON Biopharma (AMEX:AEON), Adlai Nortye (NASDAQ:ANL)